CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,439,119 | +82.8% | 636,366 | +110.2% | 0.18% | +90.5% |
Q2 2023 | $4,069,686 | -60.1% | 302,804 | -84.9% | 0.10% | -21.5% |
Q1 2019 | $10,198,000 | +158.8% | 1,999,574 | +91.8% | 0.12% | +65.8% |
Q3 2018 | $3,941,000 | +19.9% | 1,042,645 | -1.1% | 0.07% | +19.7% |
Q2 2018 | $3,288,000 | +68.4% | 1,053,871 | +29.1% | 0.06% | +60.5% |
Q1 2018 | $1,952,000 | -44.0% | 816,571 | -8.4% | 0.04% | -38.7% |
Q4 2017 | $3,484,000 | +53.5% | 891,174 | -1.0% | 0.06% | +51.2% |
Q3 2017 | $2,270,000 | -10.5% | 900,618 | -1.9% | 0.04% | -14.6% |
Q2 2017 | $2,535,000 | +464.6% | 918,438 | +298.5% | 0.05% | +500.0% |
Q1 2017 | $449,000 | +83.3% | 230,500 | -1.1% | 0.01% | +100.0% |
Q4 2016 | $245,000 | -7.5% | 233,171 | -4.1% | 0.00% | -20.0% |
Q3 2016 | $265,000 | +50.6% | 243,236 | -1.8% | 0.01% | +25.0% |
Q2 2016 | $176,000 | -38.5% | 247,711 | +1.3% | 0.00% | -33.3% |
Q1 2016 | $286,000 | -53.0% | 244,452 | -1.5% | 0.01% | -50.0% |
Q4 2015 | $608,000 | -18.6% | 248,217 | -0.3% | 0.01% | -20.0% |
Q3 2015 | $747,000 | – | 249,071 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |